Cipla recalls

Cipla has 14 recalls on record with the FDA and USDA, the earliest in 2015 and the latest reported on 10 Dec 2025. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is sterility.

Total recalls14since 2015

Last 12 months1reported

Class I00% of total

Ongoing1latest 10 Dec 2025

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 1 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 13 93%Class III 1 7%

Why cipla is recalled

Product types

Brands

By year

202517%
2022643%
2021429%
202017%
201817%
201517%

Ongoing cipla recalls

1 active

Reported	Class	Recall	Company	Reason	Where
10 Dec 2025Drug	CLASS II	Phytonadione Injectable Emulsion, USP 10mg/mL recalled by CiplaPhytonadione	Cipla	Potency & Assay	Nationwide

All cipla recalls, newest first

14 total

Reported	Class	Recall	Company	Reason	Where
10 Dec 2025Drug	CLASS II	Phytonadione Injectable Emulsion, USP 10mg/mL recalled by CiplaPhytonadione	Cipla	Potency & Assay	Nationwide
12 Oct 2022Drug	CLASS II	Arformoterol Tartrate Inhalation Solution, 15 mcg/ Sterile Unit-Dose recalledArformoterol Tartrate	Cipla	Sterility	Nationwide
5 Oct 2022Drug	CLASS II	Budesonide Inhalation Suspension 0.25mg/, For Inhalation Only recalledBudesonide	Cipla	Sterility	Nationwide
14 Sep 2022Drug	CLASS II	Difluprednate Ophthalmic Emulsion recalled by CIPLADifluprednate	Cipla	Sterility	Nationwide
14 Sep 2022Drug	CLASS II	Difluprednate Ophthalmic Emulsion recalled by CIPLA	Cipla	Sterility	Nationwide
17 Aug 2022Drug	CLASS II	Difluprednate Ophthalmic Emulsion recalled by CIPLADifluprednate	Cipla	Sterility	Nationwide
27 Jul 2022Drug	CLASS II	Difluprednate Ophthalmic Emulsion recalled by CIPLADifluprednate	Cipla	Sterility	Nationwide
21 Jul 2021Drug	CLASS II	Solifenacin Succinate Tablets, 10 mg recalled by CIPLA	Cipla	Manufacturing (CGMP) Deviations	Nationwide
6 Jan 2021Drug	CLASS II	Esomeprazole Magnesium for Delayed-Release Oral Suspension 10mg recalledEsomeprazole Magnesium	Cipla	Packaging Defects	Nationwide
6 Jan 2021Drug	CLASS II	Esomeprazole Magnesium for Delayed-Release Oral Suspension 20mg recalledEsomeprazole Magnesium	Cipla	Packaging Defects	Nationwide
6 Jan 2021Drug	CLASS II	Esomeprazole Magnesium for Delayed-Release Oral Suspension 40mg recalledEsomeprazole Magnesium	Cipla	Packaging Defects	Nationwide
23 Dec 2020Drug	CLASS II	Azacitidine for Injection 100 mg/vial For Subcutaneous recalled by CIPLA	Cipla	Sterility	Nationwide
26 Dec 2018Drug	CLASS II	Nevirapine Extended Release Tablets, 400 mg recalled by Cipla	Cipla	Potency & Assay	Nationwide
20 May 2015Drug	CLASS III	Levalbuterol Inhalation Solution, USP, 0.31 mg/ Vials recalled by Cipla	Cipla	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.